½ÃÀ庸°í¼­
»óǰÄÚµå
1530680

¼¼°èÀÇ ÀÇ·áÁ¤º¸±³È¯(HIE) ½ÃÀå ¿¹Ãø : À¯Çüº°, ±¸Çö ¸ðµ¨º°, ¼Ö·ç¼Çº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®

Health Information Exchange Market Forecasts to 2030 - Global Analysis By Type (Directed Exchange, Query-based Exchange, Consumer-mediated Exchange and Other Types), Implementation Model, Solution, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é, ¼¼°è ÀÇ·áÁ¤º¸±³È¯(HIE) ½ÃÀåÀº 2024³â 18¾ï 4,000¸¸ ´Þ·¯ ±Ô¸ðÀ̸ç, ¿¹Ãø ±â°£ µ¿¾È 9.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 35¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·áÁ¤º¸±³È¯(HIE)Àº ´Ù¾çÇÑ ÀÇ·á ±â°ü°ú ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü °£¿¡ ÀÇ·á °ü·Ã Á¤º¸¸¦ ÀüÀÚÀûÀ¸·Î °øÀ¯ÇÏ´Â °ÍÀ» ÀǹÌÇϸç, ¼­·Î ´Ù¸¥ ÀÇ·á ½Ã½ºÅÛ °£ÀÇ »óÈ£ ¿î¿ë¼ºÀ» Áö¿øÇÏ¿© ÀÇ·á ¼­ºñ½º Á¦°øÀÇ È¿À²¼ºÀ» ³ôÀÌ´Â µ¿½Ã¿¡ HIPAA¿Í °°Àº °³ÀÎ Á¤º¸ º¸È£ ±ÔÁ¤À» ÁؼöÇÒ ¼ö ÀÖµµ·Ï º¸ÀåÇÕ´Ï´Ù. º¸ÀåÇÕ´Ï´Ù. HIE´Â Á¾ÇÕÀûÀΠȯÀÚ Á¤º¸¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½ÃÅ´À¸·Î½á °Ç°­ °á°ú¸¦ °³¼±Çϰí, Áߺ¹ °Ë»ç¸¦ ÁÙÀ̸ç, ÀÇ·á ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù.

2021³â ¹Ì±¹º´¿øÇùȸÀÇ Á¶»ç µ¥ÀÌÅÍ¿¡ µû¸£¸é, ¼Ò±Ô¸ð º´¿ø°ú Áö¹æ º´¿øÀº °æÁ¦Àû, ±â¼úÀû ÀÚ¿øÀÌ Àû±â ¶§¹®¿¡ Á߱Ը𠺴¿ø°ú ´ëÇü º´¿ø¿¡ ºñÇØ HIE ³×Æ®¿öÅ©¿¡ Âü¿©ÇÏ´Â °æÇâÀÌ ³·½À´Ï´Ù.

ÄÉ¾î ¿¬°è °³¼±¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

È¿À²ÀûÀÎ µ¥ÀÌÅÍ ±³È¯Àº °Ë»ç Áߺ¹À» ÁÙÀ̰í, ÀÇ·á ½Ç¼ö¸¦ ÃÖ¼ÒÈ­Çϸç, ´õ ³ªÀº Ä¡·á °á°ú¸¦ ÃËÁøÇÕ´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ ÅëÇÕ Áø·á ¸ðµ¨À» ¿ì¼±½ÃÇÔ¿¡ µû¶ó Á¾ÇÕÀûÀΠȯÀÚ Á¤º¸¿¡ ´ëÇÑ ¿øÈ°ÇÑ Á¢±ÙÀÌ ÇʼöÀûÀÔ´Ï´Ù. ±ÔÁ¦ ÇýÅðú ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ HIE µµÀÔÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖÀ¸¸ç, ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ ½Ç½Ã°£ Ä¿¹Â´ÏÄÉÀ̼ÇÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â ȯÀÚ ¸¸Á·µµ¸¦ Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ¾÷¹« È¿À²¼ºÀ» ÃÖÀûÈ­ÇÏ¿© ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

µ¥ÀÌÅÍ À¯ÃâÀÇ À§Ç輺

ÀÇ·á Á¤º¸´Â ±â¹Ð¼ºÀÌ ³ô±â ¶§¹®¿¡ HIE ½Ã½ºÅÛ¿¡¼­ µ¥ÀÌÅÍ À¯ÃâÀº ½É°¢ÇÑ À§ÇèÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. »çÀ̹ö °ø°ÝÀº ¹«´Ü ¾×¼¼½º, µ¥ÀÌÅÍ µµ³­, ȯÀÚ ÇÁ¶óÀ̹ö½Ã Ä§ÇØ·Î À̾îÁú ¼ö ÀÖÀ¸¸ç, HIE ¼Ö·ç¼Ç¿¡ ´ëÇÑ ½Å·Ú¸¦ ¶³¾î¶ß¸± ¼ö ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ À¯Ãâ¿¡ ´ëÇÑ ±ÔÁ¦Àû ó¹úÀº HIE Âü¿©¸¦ ´õ¿í ¾ïÁ¦Çϰí, HIE ±â¼ú äÅÃÀ» Áö¿¬½Ã۸ç, ÀÇ·á ¼­ºñ½º Á¦°ø ¹× Çù·Â °³¼±¿¡ ´ëÇÑ HIEÀÇ ÀáÀçÀû ÀÌÁ¡À» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿ø°ÝÀÇ·á ¼­ºñ½º È®´ë

¿ø°Ý ÀÇ·á°¡ È®»êµÊ¿¡ µû¶ó È¿°úÀûÀÎ ¿ø°Ý ÀǷḦ Á¦°øÇϱâ À§Çؼ­´Â ȯÀÚ Á¤º¸¿¡ ´ëÇÑ ½Ç½Ã°£ ¾×¼¼½º°¡ ÇʼöÀûÀ̸ç, HIE ½Ã½ºÅÛÀº ÀÇ·á ±â·ÏÀÇ ¾ÈÀüÇÑ ±³È¯À» ÃËÁøÇϰí ÀÇ·á Çù·Â°ú ȯÀÚ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. ¶ÇÇÑ, »óÈ£ ¿î¿ë °¡´ÉÇÑ ÀÇ·á µ¥ÀÌÅÍ¿¡ ´ëÇÑ ±ÔÁ¦Àû Àμ¾Æ¼ºê´Â ÀÇ·á ±â°üÀÌ HIE ¼Ö·ç¼Ç¿¡ ÅõÀÚÇϵµ·Ï Àå·ÁÇÏ¿© ½ÃÀå ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã³ÊÁö È¿°ú¸¦ ÅëÇØ Àüü ÀÇ·á ¼­ºñ½ºÀÇ È¿À²¼º°ú ȯÀÚ ¸¸Á·µµ¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

³ôÀº Ãʱâ ÅõÀÚ ¹× À¯Áö º¸¼ö ºñ¿ë

HIE ½Ã½ºÅÛÀÇ Ãʱâ ÅõÀÚ ¹× À¯Áöº¸¼ö ºñ¿ëÀÌ ³ôÀº ÀÌÀ¯´Â °íµµÀÇ ±â¼ú ÀÎÇÁ¶ó, ¼ÒÇÁÆ®¿þ¾î °³¹ß, ±ÔÁ¦ Ç¥ÁØÀ» ÁؼöÇØ¾ß Çϱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ºñ¿ëÀº ¼Ò±Ô¸ð ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ HIE ¼Ö·ç¼ÇÀ» µµÀÔÇÏ´Â µ¥ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖÀ¸¸ç, ÀÌ´Â HIE ¼Ö·ç¼ÇÀÇ ±¤¹üÀ§ÇÑ µµÀÔÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °æÁ¦Àû ºÎ´ãÀº ½ÃÀå ÁøÀÔÀ» ÁÙÀ̰í, HIE ³×Æ®¿öÅ©ÀÇ ÅëÇÕÀ» Áö¿¬½Ã۸ç, ÀÇ·á±â°ü°ú Áö¿ªº°·Î ÀÇ·á Á¤º¸ Á¢±Ù¿¡ ´ëÇÑ °ÝÂ÷¸¦ ÃÊ·¡ÇÏ¿© ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

Äڷγª19 ÆÒµ¥¹ÍÀº ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀÌ Àû½Ã¿¡ Ä¡·á¸¦ À§ÇØ È¯ÀÚ µ¥ÀÌÅ͸¦ È¿À²ÀûÀ¸·Î °øÀ¯ÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ» ¿ä±¸Çϸ鼭 ÀÇ·áÁ¤º¸±³È¯(HIE) ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» °¡¼ÓÈ­Çß½À´Ï´Ù. ¿ø°Ý ÀÇ·á ¼­ºñ½ºÀÇ ±ÞÁõÀ¸·Î ¿øÈ°ÇÑ Á¤º¸ °øÀ¯ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö¸é¼­ HIE ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çß½À´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¿ì·Á¿Í »óÈ£¿î¿ë¼º ¹®Á¦ µîÀÇ ¹®Á¦µµ È®´ëµÇ¸é¼­ ÀÌÇØ°ü°èÀÚµéÀº À§±â »óȲ¿¡¼­ ȯÀÚÀÇ °á°ú¸¦ °³¼±Çϱâ À§ÇØ ¾ÈÀüÇϰí È¿À²ÀûÀÎ µ¥ÀÌÅÍ ±³È¯À» ¿ì¼±¼øÀ§·Î »ï°í ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È º¸¾È ¸Þ½Ã¡ ºÐ¾ß°¡ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÅ¥¾î ¸Þ½Ã¡ ºÐ¾ß´Â ¼ºÀå °¡´É¼ºÀÌ ³ôÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º¸¾È ¸Þ½Ã¡ ¿ëµµÀÇ HIE´Â ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü °£¿¡ ȯÀÚÀÇ °Ç°­ µ¥ÀÌÅ͸¦ ¾ÈÀüÇÏ°Ô °øÀ¯ÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ »óÈ£¿î¿ë¼ºÀº ÀÇ·á Çù¾÷À» °­È­Çϰí, ȯÀÚ °á°ú¸¦ °³¼±Çϸç, Áß¿äÇÑ Á¤º¸¿¡ ´ëÇÑ Àû½Ã Á¢±ÙÀ» º¸ÀåÇÕ´Ï´Ù. HIE´Â ¾Ïȣȭ¿Í º¸¾È ÀÎÁõÀ» ÅëÇØ HIPAA¿Í °°Àº °³ÀÎ Á¤º¸ º¸È£ ±ÔÁ¤À» ÁؼöÇϰí Àü¼Û ÁßÀÎ ¹Î°¨ÇÑ ÀÇ·á Á¤º¸¸¦ º¸È£ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °£¼ÒÈ­µÈ Ä¿¹Â´ÏÄÉÀ̼ÇÀº µ¥ÀÌÅÍ À¯ÃâÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­Çϸ鼭 Çù¾÷À» ÃËÁøÇϰí, ±Ã±ØÀûÀ¸·Î º¸´Ù È¿À²ÀûÀÎ ÀÇ·á ¼­ºñ½º Á¦°øÀ» Áö¿øÇÕ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü ºÐ¾ß°¡ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, HIE ¿ëµµ´Â ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ ¼­·Î ´Ù¸¥ ½Ã½ºÅÛ ¹× Á¶Á÷ °£¿¡ ȯÀÚ µ¥ÀÌÅ͸¦ ¾ÈÀüÇÏ°Ô °øÀ¯ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÌ·¯ÇÑ ¿ëµµ´Â ÀÇ·á ±â·Ï, °Ë»ç °á°ú, Ä¡·á À̷¿¡ ´ëÇÑ ½Ç½Ã°£ ¾×¼¼½º¸¦ ¿ëÀÌÇÏ°Ô ÇÏ¿© Áø·á Á¶Á¤À» °³¼±ÇÏ°í ¼­ºñ½º Áߺ¹À» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. HIE ¿ëµµ´Â °ü·Ã Á¤º¸¸¦ Áï½Ã »ç¿ëÇÒ ¼ö ÀÖµµ·Ï ÇÔÀ¸·Î½á ÀÓ»óÀû ÀÇ»ç°áÁ¤À» °­È­Çϰí, ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϸç, ±Ã±ØÀûÀ¸·Î HIPAA¿Í °°Àº °³ÀÎ Á¤º¸ º¸È£ ±ÔÁ¤À» ÁؼöÇϸ鼭 ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

¾ÆÅÂÁö¿ªÀº ÇコÄɾîÀÇ µðÁöÅÐÈ­ ¹ßÀü°ú ÀÇ·á ¼­ºñ½º ¿¬°è °³¼±¿¡ ´ëÇÑ ¼ö¿ä·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °¢±¹ Á¤ºÎ´Â µðÁöÅÐ Çコ ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç, ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü °£ÀÇ Çù¾÷À» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿ø°Ý ÀÇ·á¿Í ¸ð¹ÙÀÏ ÀÇ·á ¿ëµµ Áõ°¡´Â HIEÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº µ¥ÀÌÅÍ °øÀ¯¿Í º¸¾ÈÀ» °­È­ÇÏ´Â Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖÀ¸¸ç, Áö¿ª Àüü¿¡¼­ ȯÀÚ °á°ú¿Í ¿î¿µ È¿À²¼ºÀ» °³¼±Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª :

ºÏ¹Ì´Â ÀüÀÚ ÀÇ·á ±â·Ï(EHR)ÀÇ ±¤¹üÀ§ÇÑ µµÀÔ°ú HIPAA¿Í °°Àº ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°ÇÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀº ´Ù¾çÇÑ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü °£ÀÇ »óÈ£ ¿î¿ë °¡´ÉÇÑ ÀÇ·á µ¥ÀÌÅÍ ±³È¯À» Áö¿øÇÏ´Â ¼º¼÷ÇÑ ÀÎÇÁ¶ó¸¦ ÀÚ¶ûÇÕ´Ï´Ù. ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÀÇ·á ¼­ºñ½º Á¦°øÀÇ ÃÖÀûÈ­¿Í ºñ¿ë Àý°¨À» À§ÇØ HIE¿Í Áý´Ü °Ç°­ °ü¸® ½Ã½ºÅÛ ¹× ºÐ¼® µµ±¸ÀÇ ÅëÇÕÀÌ Æ÷ÇԵ˴ϴÙ.

¹«·á Ä¿½ºÅ͸¶ÀÌ¡ Á¦°ø:

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(ÃÖ´ë 3°³»ç)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤Ä¡, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º È®Àο¡ µû¶ó ´Ù¸§)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç Á¤º¸¿ø
    • 1Â÷ Á¶»ç Á¤º¸¿ø
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå PorterÀÇ Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ÀÇ·áÁ¤º¸±³È¯(HIE) ½ÃÀå : À¯Çüº°

  • Directed Exchange
  • Query-based Exchange
  • Consumer-mediated Exchange
  • ±âŸ À¯Çü

Á¦6Àå ¼¼°èÀÇ ÀÇ·áÁ¤º¸±³È¯(HIE) ½ÃÀå : ½ÇÀå ¸ðµ¨º°

  • ÁýÁßÇü ¸ðµ¨
  • ºÐ»êÇü/¿¬ÇÕÇü ¸ðµ¨
  • ÇÏÀ̺긮µå ¸ðµ¨

Á¦7Àå ¼¼°èÀÇ ÀÇ·áÁ¤º¸±³È¯(HIE) ½ÃÀå : ¼Ö·ç¼Çº°

  • Æ÷ÅÐ Á᫐ ¼Ö·ç¼Ç
  • ¸Þ½Ã¡ Á᫐ ¼Ö·ç¼Ç
  • Ç÷§Æû Á᫐ ¼Ö·ç¼Ç
  • ±âŸ ¼Ö·ç¼Ç

Á¦8Àå ¼¼°èÀÇ ÀÇ·áÁ¤º¸±³È¯(HIE) ½ÃÀå : ¿ëµµº°

  • ³»ºÎ ÀÎÅÍÆäÀ̽º
  • ¾ÈÀüÇÑ ¸Þ½Ã¡
  • ¿öÅ©ÇÃ·Î¿ì °ü¸®
  • À¥ Æ÷ÅÐ °³¹ß
  • ±âŸ ¿ëµµ

Á¦9Àå ¼¼°èÀÇ ÀÇ·áÁ¤º¸±³È¯(HIE) ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ÀÇ·á Á¦°øÀÚ
  • ¾à±¹
  • º¸Çè ȸ»ç
  • °øÁßÀ§»ý±â°ü
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦10Àå ¼¼°èÀÇ ÀÇ·áÁ¤º¸±³È¯(HIE) ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä ¹ßÀü

  • °è¾à/ÆÄÆ®³Ê½Ê/Çù¾÷/ÇÕÀÛÅõÀÚ(JV)
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • GE Healthcare
  • Koninklijke Philips N.V.
  • Optum
  • IBM Watson Health
  • InterSystems Corporation
  • Orion Health
  • MEDITECH
  • NextGen Healthcare
  • eClinicalWorks
  • McKesson Corporation
  • Cerner Corporation
  • Allscripts Healthcare Solutions
  • Epic Systems Corporation
  • eHealth Inc.
  • United Health Group
LSH 24.08.22

According to Stratistics MRC, the Global Health Information Exchange Market is accounted for $1.84 billion in 2024 and is expected to reach $3.56 billion by 2030 growing at a CAGR of 9.6% during the forecast period. Health information exchange refers to the electronic sharing of health-related information among various healthcare organizations and providers. HIE supports interoperability between disparate healthcare systems, enhancing the efficiency of care delivery while ensuring compliance with privacy regulations like HIPAA. By improving access to comprehensive patient information, HIE aims to improve health outcomes, reduce duplicate testing, and streamline healthcare workflows.

According to 2021 American Hospital Association survey data, small and rural hospitals are less likely to participate in HIE networks than medium and large hospitals due to fewer economic and technological resources.

Market Dynamics:

Driver:

Growing demand for improved care coordination

Efficient data exchange reduces duplication of tests, minimizes medical errors, and fosters better treatment outcomes. As healthcare systems prioritize integrated care models, the need for seamless access to comprehensive patient information becomes essential. Regulatory incentives and advancements in technology further support HIE adoption, enabling real-time communication across diverse healthcare settings. This shift not only improves patient satisfaction but also optimizes operational efficiencies, propelling market growth.

Restraint:

Risks of data breaches

Data breaches in HIE systems pose significant risks due to the sensitive nature of health information. Cyber attacks can lead to unauthorized access, data theft, and compromised patient privacy, undermining trust in HIE solutions. Regulatory penalties for data breaches further deter participation, slowing the adoption of HIE technology and impeding its potential benefits for improved healthcare delivery and coordination.

Opportunity:

Expansion of telehealth services

As telehealth adoption rises, the need for real-time access to patient information becomes crucial for delivering effective remote care. HIE systems facilitate the secure exchange of health records, improving care coordination and patient outcomes. Additionally, regulatory incentives for interoperable health data encourage healthcare organizations to invest in HIE solutions, further accelerating market growth. This synergy enhances overall healthcare efficiency and patient satisfaction.

Threat:

High initial investments and maintenance costs

High initial investments and maintenance costs in HIE systems stem from the need for advanced technology infrastructure, software development, and compliance with regulatory standards. These expenses can deter smaller healthcare providers from adopting HIE solutions, limiting widespread implementation. This financial burden hampers market growth by reducing participation, slowing down the integration of HIE networks, and creating disparities in health information access across different healthcare organizations and regions.

Covid-19 Impact

The covid-19 pandemic accelerated the adoption of health information exchange (HIE) solutions as healthcare providers sought efficient ways to share patient data for timely care. The surge in telehealth services heightened the need for seamless information sharing, leading to increased investments in HIE technology. However, challenges such as data privacy concerns and interoperability issues were also magnified, prompting stakeholders to prioritize secure and efficient data exchange to improve patient outcomes during the crisis.

The secure messaging segment is expected to be the largest during the forecast period

The secure messaging segment is estimated to have a lucrative growth. HIE in secure messaging applications facilitates the secure sharing of patient health data among healthcare providers. This interoperability enhances care coordination, improves patient outcomes, and ensures timely access to critical information. By utilizing encryption and secure authentication, HIE protects sensitive health information during transmission, adhering to privacy regulations like HIPAA. This streamlined communication fosters collaboration while minimizing the risk of data breaches, ultimately supporting more efficient healthcare delivery.

The healthcare providers segment is expected to have the highest CAGR during the forecast period

The healthcare providers segment is anticipated to witness the highest CAGR growth during the forecast period. HIE applications enable healthcare providers to securely share patient data across different systems and organizations. These applications facilitate real-time access to medical records, lab results, and treatment histories, improving care coordination and reducing duplication of services. By ensuring that relevant information is readily available, HIE applications enhance clinical decision-making, streamline workflows, and ultimately lead to better patient outcomes while maintaining compliance with privacy regulations like HIPAA.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period due to increasing healthcare digitization and the demand for improved care coordination. Governments are investing in digital health initiatives, fostering collaboration among healthcare providers. The rise of telemedicine and mobile health applications is further driving HIE adoption. Major players in the market are focusing on innovative solutions to enhance data sharing and security, aiming to improve patient outcomes and operational efficiencies across the region.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, driven by extensive adoption of electronic health records (EHR) and stringent regulatory requirements like HIPAA. The region boasts a mature infrastructure supporting interoperable health data exchange among diverse healthcare providers. Key trends include the integration of HIE with population health management systems and analytics tools to optimize care delivery and reduce costs.

Key players in the market

Some of the key players profiled in the Health Information Exchange Market include GE Healthcare, Koninklijke Philips N.V., Optum, IBM Watson Health, InterSystems Corporation, Orion Health, MEDITECH, NextGen Healthcare, eClinicalWorks, McKesson Corporation, Cerner Corporation, Allscripts Healthcare Solutions, Epic Systems Corporation, eHealth Inc. and United Health Group.

Key Developments:

In April 2024, UnitedHealth Group announced support for people who may be concerned about their personal data potentially being impacted based on preliminary findings from the ongoing investigation and review of the data involved in the malicious criminal cyberattack on Change Healthcare. The company is also providing an update on progress in restoring Change Healthcare's products and services.

In November 2023, The eHealth Exchange HIE has launched a program aimed at accelerating the adoption of HL7 FHIR (Fast Healthcare Interoperability Resources). The program aims to encourage and support the implementation of HL7 FHIR, which is a standard for exchanging healthcare information electronically.

Types Covered:

  • Directed Exchange
  • Query-based Exchange
  • Consumer-mediated Exchange
  • Other Types

Implementation Models Covered:

  • Centralized Models
  • Decentralized/Federated Models
  • Hybrid Models

Solutions Covered:

  • Portal-centric Solutions
  • Messaging-centric Solutions
  • Platform-centric Solutions
  • Other Solutions

Applications Covered:

  • Internal Interfacing
  • Secure Messaging
  • Workflow Management
  • Web Portal Development
  • Other Applications

End Users Covered:

  • Healthcare Providers
  • Pharmacies
  • Insurance Companies
  • Public Health Agencies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Health Information Exchange Market, By Type

  • 5.1 Introduction
  • 5.2 Directed Exchange
  • 5.3 Query-based Exchange
  • 5.4 Consumer-mediated Exchange
  • 5.5 Other Types

6 Global Health Information Exchange Market, By Implementation Model

  • 6.1 Introduction
  • 6.2 Centralized Models
  • 6.3 Decentralized/Federated Models
  • 6.4 Hybrid Models

7 Global Health Information Exchange Market, By Solution

  • 7.1 Introduction
  • 7.2 Portal-centric Solutions
  • 7.3 Messaging-centric Solutions
  • 7.4 Platform-centric Solutions
  • 7.5 Other Solutions

8 Global Health Information Exchange Market, By Application

  • 8.1 Introduction
  • 8.2 Internal Interfacing
  • 8.3 Secure Messaging
  • 8.4 Workflow Management
  • 8.5 Web Portal Development
  • 8.6 Other Applications

9 Global Health Information Exchange Market, By End User

  • 9.1 Introduction
  • 9.2 Healthcare Providers
  • 9.3 Pharmacies
  • 9.4 Insurance Companies
  • 9.5 Public Health Agencies
  • 9.6 Other End Users

10 Global Health Information Exchange Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 GE Healthcare
  • 12.2 Koninklijke Philips N.V.
  • 12.3 Optum
  • 12.4 IBM Watson Health
  • 12.5 InterSystems Corporation
  • 12.6 Orion Health
  • 12.7 MEDITECH
  • 12.8 NextGen Healthcare
  • 12.9 eClinicalWorks
  • 12.10 McKesson Corporation
  • 12.11 Cerner Corporation
  • 12.12 Allscripts Healthcare Solutions
  • 12.13 Epic Systems Corporation
  • 12.14 eHealth Inc.
  • 12.15 United Health Group
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦